This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2019 Feb;290(2):357-358.

doi: 10.1148/radiol.2018182179. Epub 2018 Nov 6.

Is RECIST Version 1.1 Reliable for Tumor Response Assessment in Metastatic Cancer?

Affiliations

PMID: 30398437
DOI: 10.1148/radiol.2018182179

Editorial

Is RECIST Version 1.1 Reliable for Tumor Response Assessment in Metastatic Cancer?

Jacob Sosna. Radiology. 2019 Feb.

. 2019 Feb;290(2):357-358.

doi: 10.1148/radiol.2018182179. Epub 2018 Nov 6.

Author

Affiliation

¹ From the Department of Radiology, Hadassah Medical Center, Hebrew University, Ein Kerem, POB 12000, Jerusalem, Israel.

PMID: 30398437
DOI: 10.1148/radiol.2018182179

No abstract available

PubMed Disclaimer

Comment on

Validity of RECIST Version 1.1 for Response Assessment in Metastatic Cancer: A Prospective, Multireader Study.
Kuhl CK, Alparslan Y, Schmoee J, Sequeira B, Keulers A, Brümmendorf TH, Keil S. Kuhl CK, et al. Radiology. 2019 Feb;290(2):349-356. doi: 10.1148/radiol.2018180648. Epub 2018 Nov 6. Radiology. 2019. PMID: 30398433

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon